Back to Overview
Martin Fabry PhD
Martin Fabry finished his bachelor’s degree in molecular biomedicine at the University of Bonn in 2014 and moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York, US) working on improving CRISPR/Cas9 technologies. Following completion of a master’s degree in life and medical sciences in 2016 with emphasis on molecular mechanisms of immunity, Martin started his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge studying genome organisation and stability.
After graduating with his doctorate degree in 2020, Martin worked as postdoctoral fellow in computational biology at the Gurdon Institute and European Bioinformatics Institute (EBI) in Cambridge with focus on stem cell development and establishing new technologies for stem cell differentiation.
Martin joined IP2 in 2018 as scientific consultant and started as a patent attorney candidate in late 2021.
- Life Science 100%
What more there is to say...
In his leisure time Martin likes running, hiking, diving and rowing.
What moves me
Russian Warship…
...Go F**k yourself! … was the final communication made on 24 February, the first day of the 2022 Snake Island campaign, by Ukrainian border guard Roman Hrybov to the Russian missile cruiser Moskva just before the ship opened fire on Sevastopol. The phrase went viral...
Dr. Dietmar Pressner – New Kid on the Block
Introducing Dr. Dietmar Pressner We proudly announce that Dr. Dietmar Pressner has joined our IP2 team as a Senior Patent Advisor, responsible for chemical cases and IP strategy. Originally qualified as a PhD. in Chemistry completed at the Max Planck Institute for...
Nagoya Protocol 2.0
Additional New White Paper from IP2 concerning the Nagoya Protocol Our white paper "10 years of the Nagoya Protocol" from late 2023 explains the background, summarizes the current implementation into national law and provides an overview of the requirements that...
Back to Overview